On the renal basis for essential hypertension: Nephron heterogeneity with discordant renin secretion and sodium excretion causing a hypertensive vasoconstriction-volume relationship

Journal of Hypertension

Volumn 6, Issue 10, 1988, Pages 763-777

  Sealey, Jean E ^a   Blumenfeld, Jon D ^a   Bell, Gordon M ^a   Pecker, Mark S ^a   Sommers, Sheldon C ^a   Laragh, John H ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

Aldosterone; Angiotensin; Baroreceptor; Hypernatriuresis; Hypertension; Kidney; Macula densa; Nephron heterogeneity; Rennin; Sodium; Tubuloglomerular feedback

Indexed keywords

ANGIOTENSIN; RENIN; SODIUM;

HUMAN; HYPERTENSION; KIDNEY FUNCTION; NEPHRON; ESSENTIAL HYPERTENSION; ISCHEMIA; KIDNEY TUBULOGLOMERULAR FEEDBACK; MACULA DENSA; REVIEW; SODIUM EXCRETION; VASOCONSTRICTION;

HOMEOSTASIS; HUMAN; HYPERTENSION; HYPERTENSION, RENOVASCULAR; MODELS, THEORETICAL; NATRIURESIS; NEPHRONS; PRESSORECEPTORS; RENAL ARTERY OBSTRUCTION; RENAL CIRCULATION; RENIN;

EID: 0024238476     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/00004872-198811000-00001     Document Type: Article

References (67)

1. Laragh JH, Sealey JE: The renin-angiotensin-aldosterone hormonal system and regulation of sodium, potassium, and blood pressure homeostasis. In Handbook of Physiology - Renal Physiology edited by Orloff J, Berliner RW. Bethesda: American Physiological Society 1973, pp 831–908.
2. Laragh JH, Sealey JE, Niarchos AP, Pickering TG: The vaso-constriction-volume spectrum in normotension and pathogenesis of hypertension. Fed Proc 1982, 41:2415–2423.
3. Laragh JH, Resnick LM: Recognizing and treating two types of long-term vasoconstriction in hypertension. Kidney Int 1988, 34 (suppl 25):S162–S174.
4. Tobian L: Interrelationships of electrolytes, juxtaglomerular cells and hypertension. Physiol Rev 1960, 40:280–312.
5. Vander AJ: Control of renin release. Physiol Rev 1967, 47:359–382.
6. Sommers SC, Reiman AS, Smithwick RH: Histologic studies of kidney biopsy specimens from patients with hypertension. Am J Pathol 1958, 34:685–715.
7. Sommers SC: Hypertension and kidney disease. Prog Cardiovasc Dis 1965, 8:210–234.
8. Turgeon C, Sommers SC: Juxtaglomerular cell counts and human hypertension. Am J Pathol 1961, 38:227–241.
9. Sealey JE, Moon C, Laragh JH, Atlas SA: Plasma prorenin in normal, hypertensive and anephric subjects and its effect on renin measurements. Circ Res 1977, 40 (suppl 1):41–45.
10. Sealey JE, White RP, Laragh JH, Case DB, Rubin AL: Studies of plasma aldosterone in anephric people: evidence for the fundamental role of the renin system in maintaining aldosterone secretion. J Clin Endocrinol Metab 1978, 47:42–60.
11. Sealey JE, Atlas SA, Laragh JH: Prorenin and other large molecular weight forms of renin. Endocr Rev 1980, 1:365–391.
12. Skott O, Briggs JP: Direct demonstration of macula densa-mediated renin secretion. Science 1987, 237:1618–1620.
13. Fray JCS, Lush DJ: Stretch receptor hypothesis for renin secretion: the role of calcium. J Hypertension 1984, 2 (suppl 1):19–23.
14. Laragh JH: The meaning of plasma renin measurements: renin and sodium-volume-mediated (low renin) forms of vasoconstriction in experimental and human hypertension and in the oedematous states of nephrosis and heart failure. J Hypertension 1984, 2 (suppl 1):141–150.
15. Brenner BM, Garcia DL, Anderson S: Glomeruli and blood pressure: less of one, more of the other? Am J Hypertens 1988 1:335–347.
16. Brunner HR, Laragh JH, Baer L, Newton MA, Goodwin FT, Krakoff LR, Bard RH, Bühler FR: Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med 1972, 286:441–449.
17. Laragh JH: Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles. Am J Med 1973, 55:261–274.
18. Case DB, Atlas SA, Laragh JH, Sealey JE, Sullivan PA, McKinstry DN: Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, Captopril) in hypertensive patients. Progr Cardiovasc Dis 1978, 31:195–206.
19. Case DB, Wallace JM, Keim HJ, Weber MA, Sealey JE, Laragh JH: Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme. N Engl J Med 1977, 296:641–646.
20. Case DB, Wallace JM, Keim HJ, Weber MA, Drayer JIM, White RP, Sealey JE, Laragh JH: Estimating renin participation in hypertension. Superiority of converting enzyme inhibitior over Saralasin. Am J Med 1976, 61:790–796.
21. Case DB, Atlas SA, Laragh JH: Physiologic effects and diagnostic relevance of acute converting enzyme blockade. In Frontiers in Hypertension Research edited by Laragh JH, Bühler FR, Seldin DW. New York: Springer-Verlag, 1981, pp 541–550.
22. Collins RD, Weinberger MJ, Dowdy AJ, Nokes GW, Gonzales CM, Luetscher JA: Abnormally sustained aldosterone secretion during salt loading in patients with various forms of benign hypertension; relation to plasma renin activity. J Clin Invest 1970, 49:1415–1526.
23. Weber MA, Drayer JIM, Rev A, Laragh JH: Disparate patterns of aldosterone response during diuretic treatment of hypertension. Ann Intern Med 1977, 87:558–563.
24. Gavras H, Brunner HR, Laragh JH, Sealey JE, Gavras I, Vukovitch RA: An angiotensin converting enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients. N Engl J Med 1974, 291:817–821.
25. Pecker MS, Cody RJ, Laragh JH, Sala C, Atlas SA: Effect of saline infusion on plasma ANF in normal and hypertensive subjects. Program and Abstracts, Second World Congress on Biologically Active Atrial Peptides 1987, p 228 (abstract No. B.179).
26. Farnsworth EB: Renal reabsorption of chloride and phosphate in normal subjects and in patients with essential arterial hypertension. J Clin Invest 1946, 25:897–905.
27. Grim CE, Luft FC, Fineberg NS, Weinberger MH: Respnses to volume expansion and contraction in categorized hypertensive and normotensive man. Hypertension 1979, 1:476–485.
28. Cottier PT, Weller JM, Hoobler SW: Effect of an intravenous sodium chloride load on renal hemodynamics and electrolyte excretion in essential hypertension. Circulation 1958, 17:750–760.
29. Luft F, Weinberg MH: Determinants of exaggerated natriuresis in arterial hypertension. In Kidney in Essential Hypertension edited by Messerli FH. Boston: Martinus Nijhoff Publishing, 1984, pp 105–123.
30. Hollander W, Judson WE: Electrolyte and water excretion in arterial hypertension. I. Studies in non-medically treated subjects with essential hypertension. J Clin Invest 1957, 36:1460–1469.
31. Papper S, Belsky JL, Bleifer KH: The response to the administration of an isotonic sodium chloride-lactate solution in patients with essential hypertension. J Clin Invest 1960, 39:876–884.
32. Smith HW: Salt and water volume receptors: An exercise in physiologic apologetics. Am J Med 1957, 23:623–652.
33. Hollander W, Judson WE: Electrolyte and water excretion in arterial hypertension. II. Studies in subjects with essential hypertension after antihypertensive drug treatment. Circulation 1958, 17:576–582.
34. Green DM, Ellis EJ: Sodium output-blood pressure relationships and their modification by treatment. Circulation 1954, 10:536–543.
35. Luft FC, Rankin LI, Bloch R, Weyman AE, Willis LR, Murray RH, Grim CE, Weinberger MH: Cardiovascular and humoral responses to extremes of sodium intake in normal black and white men. Circulation 1979, 60:697–706.
36. Buckalew VM, Puschett JB, Kintzel JE, Goldberg M: Mechanism of exaggerated natriuresis in hypertensive man: impaired sodium transport in the loop of Henle. J Clin Invest 1969, 48:1007–1016.
37. Cannon PJ: Effects of five per cent dextrose-water infusions in normal and hypertensive man. Evidence for increased proximal and distal tubular sodium rejection by hypertensive patients and its relation to renal hemodynamics. Circulation 1968. 37:832–846.
38. Gottschalk GW, Mylle M: Micropuncture study of pressures in proximal tubules and peritubular capillaries of the rat kidney and their relation to ureteral and renal venous pressures. Am J Physiol 1956, 185:430–439.
39. Wirz H: Druckmessung in Kapillaren und Tubuli der Niere durch Mikropunktion. Helv Physiol Pharmacol Acta 1955, 13:42–49.
40. Lowenstein J, Beranbaum ER, Chassis H, Baldwin DS: Intrarenal pressure and exaggerated natriuresis in essential hypertension. Clin Sci 1970, 38:359–374.
41. Krakoff LR, Goodwin FJ, Baer L, Torres M, Laragh JH: The role of renin in the exaggerated natriuresis of hypertension. Circulation 1970, 42:335–345.
42. Luft FC, Grim CE, Willis LR, Higgins JT, Weinberger MH: Natriuretic response to saline infusion in normotensive and hypertensive man. The role of renin suppression in exaggerated natriuresis. Circulation 1977, 55:779–784.
43. Laragh JH, Cannon PJ, Ames RP: Aldosterone secretion and various forms of hypertensive vascular disease. Ann Intern Med 1963, 59:117–120.
44. Biglieri EG, Forsham PH: Studies on the expanded extracellular fluid and the responses to various stimuli in primary aldosteronism. Am J Med 1961, 30:564–575.
45. Bradley SE, Chasis H, Goldring W, Smith HW: Hemodynamic alterations in normotensive and hypertensive subjects during the pyrogenic reaction. J Clin Invest 1945, 24:749–758.
46. Hollenberg NE, Borucki LS, Adams DF: The renal vascular lesion in early essential hypertension: Evidence for a pathogenetic role. Medicine 1978, 57:167–178.
47. Keeton TK, Campbell WB: The pharmacologic alteration of renin release. Pharmacol Rev 1981, 31:81–227.
48. Churchill PC: Calcium channel antagonists and renin release. Am J Nephrol 1987, 7 (suppl 1):32–38.
49. Hall JE, Guyton AC, Smith MJ, Coleman TG: Blood pressure and renal function during chronic changes in sodium intake: role of angiotensin. Am J Physiol 1980, 239:F271–F280.
50. Bühler FR, Laragh JH, Baer L, Vaughan ED Jr, Brunner HR: Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases. N Engl J Med 1972, 287:1209–1214.
51. Malnic G, Klose RM, Giebisch G: Microperfusion study of distal tubular potassium and sodium transfer in rat kidney. Am J Physiol 1966, 211:548–559.
52. Sealey JE, Bühler FR, Laragh JH, Vaughn ED Jr: The physiology of renin secretion in essential hypertension: Estimation of renin secretion rate and renal plasma flow from peripheral and renal vein renin levels. Am J Med 1973, 55:391–401.
53. Laragh JH: Renovascular hypertension: A paradigm for all hypertension. J Hypertension 1986, 5 (suppl 4):S79–S88.
54. Hall JE, Guyton AC, Jackson TE, Coleman TG, Lohmeier TE, Trippodo NC: Control of glomerular filtration rate by renin-angiotensin system. Am J Physiol 1977, 233:F366–F372.
55. Ichikawa I, Brenner BM: Importance of efferent arteriolar vascular tone in regulation of proximal tubule fluid reabsorption and glomerulotubular balance in the rat. J Clin Invest 1980, 654:1192–1201.
56. Hall JE, Granger JP: Renal hemodynamic actions of angiotensin II: interaction with tubuloglomerular feedback. Am J Physiol 1983, 245:R166–R173.
57. Harris PJ, Navar LG: Tubular transport responses to angiotensin. Am J Physiol 1985, 248:F621–F630.
58. Schuster VL: Angiotensin effects on proximal tubular reabsorption. Fed Proc 1986, 45:1444–1447.
59. Schnerman J, Haeberle DA, Davis JM, Thurau K: Tubuloglomerular feedback control of renal vascular resistance. In Handbook of Physiology-Renal Physiology, 2nd edn, edited by Orloff J, Berliner RW. Bethesda: American Physiological Society (forthcoming).
60. Mitchell KD, Navar LG: Amplifications of tubuloglomerular feedback responses during peritubular capillary infusions of angiotensins I and II. Am J Physiol 1988, 225:F383–F390.
61. Navar LG, Carmines PK, Huang WC, Mitchell KD: The tubular effefcts of angiotensin II. Kidney Int 1987, 31 (suppl 20):S81–S88.
62. James GD, Sealey JE, Müller FB, Alderman M, Madhavan S, Laragh JH: Renin relationship to sex, race and age in a normotensive population. J Hypertension 1986, 4 (suppl 5):S387–S389.
63. Hollenberg NK, Williams GH: Abnormal renal function, sodium-volume homeostasis, and renin-system behavior in normal-renin essential hypertension. In Hypertension: Pathophysiology, Diagnosis, and Treatment edited by Laragh JH, Brenner BM. New York: Raven Press (forthcoming).
64. Bradley SE: Physiology of essential hypertension. Am J Med 1948, 4:398–415.
65. Chasis H, Goldring W, Breed E, Bolomey A, Smith HW: Effects of salt and protein restriction on blood pressure and renal hemodyanmics in hypertensive patients. J Clin Invest 1949, 28:775 (abstract);.
66. Goldring W, Chasis H, Ranges HA, Smith HW: Effective renal blood flow in subjects with essential hypertension. J Clin Invest 1941, 20:637–653.
67. Bradley SE, Curry JJ, Bradley GP: Renal extraction of P-amino-hippurate in normal subjects and essential hypertension and chronic diffuse glomerulonephritis. Fed Proc 1947, 6:79–80 (abstract).